Morgan Stanley
MPT

Morgan Stanley’s Medical Properties Trust MPT Stock Holding History

Morgan Stanley’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.2M Sell
6,734,293
-5,220,570
-44% -$27.2M ﹤0.01% 2545
2025
Q4 		$59.8M Buy
11,954,863
+5,375,128
+82% +$28M ﹤0.01% 1919
2025
Q3 		$33.4M Sell
6,579,735
-1,008,786
-13% -$4.44M ﹤0.01% 2389
2025
Q2 		$32.7M Sell
7,588,521
-1,045,542
-12% -$5.17M ﹤0.01% 2316
2025
Q1 		$52.1M Buy
8,634,063
+1,648,624
+24% +$8.34M ﹤0.01% 1781
2024
Q4 		$27.6M Sell
6,985,439
-1,731,003
-20% -$7.75M ﹤0.01% 2434
2024
Q3 		$51M Sell
8,716,442
-1,334,679
-13% -$6.58M ﹤0.01% 1808
2024
Q2 		$43.3M Sell
10,051,121
-1,557,841
-13% -$7.46M ﹤0.01% 1892
2024
Q1 		$54.6M Sell
11,608,962
-5,326,084
-31% -$20.4M ﹤0.01% 1682
2023
Q4 		$83.2M Buy
16,935,046
+10,897,223
+180% +$53.4M ﹤0.01% 1928
2023
Q3 		$32.9M Sell
6,037,823
-3,853,998
-39% -$30.9M ﹤0.01% 1960
2023
Q2 		$91.6M Buy
9,891,821
+611,430
+7% +$5.17M 0.01% 1144
2023
Q1 		$76.3M Buy
9,280,391
+356,757
+4% +$3.94M 0.01% 1221
2022
Q4 		$99.4M Buy
8,923,634
+1,387,675
+18% +$16.1M 0.01% 1033
2022
Q3 		$89.4M Buy
7,535,959
+1,639,446
+28% +$24.8M 0.01% 956
2022
Q2 		$90M Buy
5,896,513
+432,681
+8% +$7.78M 0.01% 984
2022
Q1 		$116M Buy
5,463,832
+773,405
+16% +$16.7M 0.02% 778
2021
Q4 		$111M Buy
4,690,427
+349,260
+8% +$7.48M 0.01% 836
2021
Q3 		$87.1M Sell
4,341,167
-160,815
-4% -$3.3M 0.01% 920
2021
Q2 		$90.5M Buy
4,501,982
+1,115,386
+33% +$23.9M 0.01% 910
2021
Q1 		$72.1M Sell
3,386,596
-371,250
-10% -$7.98M 0.01% 944
2020
Q4 		$81.9M Buy
3,757,846
+2,555,662
+213% +$49.8M 0.01% 811
2020
Q3 		$21.2M Sell
1,202,184
-358,683
-23% -$6.67M ﹤0.01% 1444
2020
Q2 		$29.3M Sell
1,560,867
-424,414
-21% -$7.52M 0.01% 1152
2020
Q1 		$34.3M Sell
1,985,281
-395,304
-17% -$8.27M 0.01% 935
2019
Q4 		$50.3M Buy
2,380,585
+236,348
+11% +$4.78M 0.01% 925
2019
Q3 		$41.9M Buy
2,144,237
+212,033
+11% +$3.89M 0.01% 962
2019
Q2 		$33.7M Sell
1,932,204
-496,116
-20% -$8.93M 0.01% 1102
2019
Q1 		$44.9M Sell
2,428,320
-69,172
-3% -$1.23M 0.01% 909
2018
Q4 		$40.2M Buy
2,497,492
+648,943
+35% +$10.3M 0.01% 935
2018
Q3 		$27.6M Buy
1,848,549
+182,975
+11% +$2.67M 0.01% 1398
2018
Q2 		$23.4M Buy
1,665,574
+85,876
+5% +$1.14M 0.01% 1497
2018
Q1 		$20.5M Buy
1,579,698
+109,673
+7% +$1.4M 0.01% 1643
2017
Q4 		$20.3M Sell
1,470,025
-203,651
-12% -$2.75M 0.01% 1652
2017
Q3 		$22M Sell
1,673,676
-698,282
-29% -$8.99M 0.01% 1500
2017
Q2 		$30.5M Buy
2,371,958
+501,693
+27% +$6.68M 0.01% 1200
2017
Q1 		$24.1M Sell
1,870,265
-338,460
-15% -$4.33M 0.01% 1404
2016
Q4 		$27.2M Buy
2,208,725
+1,131,266
+105% +$14.6M 0.01% 1277
2016
Q3 		$15.9M Buy
1,077,459
+136,795
+15% +$2.07M 0.01% 1629
2016
Q2 		$14.3M Buy
940,664
+222,745
+31% +$3.15M 0.01% 1687
2016
Q1 		$9.32M Sell
717,919
-360,375
-33% -$4.11M ﹤0.01% 1915
2015
Q4 		$12.4M Sell
1,078,294
-431,474
-29% -$4.93M ﹤0.01% 1787
2015
Q3 		$16.7M Buy
1,509,768
+669,055
+80% +$8.3M 0.01% 1536
2015
Q2 		$11M Sell
840,713
-545,337
-39% -$7.6M ﹤0.01% 2016
2015
Q1 		$20.4M Sell
1,386,050
-142,706
-9% -$2.12M 0.01% 1447
2014
Q4 		$21.1M Buy
1,528,756
+280,987
+23% +$3.76M 0.01% 1453
2014
Q3 		$15.3M Sell
1,247,769
-272,748
-18% -$3.63M 0.01% 1649
2014
Q2 		$20.1M Sell
1,520,517
-284,425
-16% -$3.78M 0.01% 1430
2014
Q1 		$23.1M Sell
1,804,942
-222,071
-11% -$2.85M 0.01% 1267
2013
Q4 		$24.8M Buy
2,027,013
+679,286
+50% +$8.67M 0.01% 1183
2013
Q3 		$16.4M Buy
1,347,727
+559,763
+71% +$7.48M 0.01% 1379
2013
Q2 		$11.3M Buy
+787,964
New +$12.4M 0.01% 1609

Other funds holding MPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Morgan Stanley's MPT Position: Q1 2026 in Review

Morgan Stanley reduced its Medical Properties Trust (MPT) stake by 44% in Q1 2026, selling an estimated $27.2M and leaving 6,734,293 shares worth $31.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2545.

Morgan Stanley first reported a position in MPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $116M in Q1 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Morgan Stanley held 6,734,293 shares of Medical Properties Trust worth $31.2M as of Q1 2026.
  • Morgan Stanley sold 5,220,570 Medical Properties Trust shares in Q1 2026, an estimated $27.2M.
  • Medical Properties Trust made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2545 holding.
  • Morgan Stanley first reported a position in Medical Properties Trust in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's Medical Properties Trust position peaked at $116M in Q1 2022.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.